Comparison of diagnostic and treatment processes among pediatric and adolescents and young adults’ populations suffering from acute lymphoblastic leukemia and lymphomas
暂无分享,去创建一个
[1] Y. Nieto,et al. Management of Aggressive Non-Hodgkin Lymphomas in the Pediatric, Adolescent, and Young Adult Population: An Adult vs. Pediatric Perspective , 2022, Cancers.
[2] O. Husson,et al. Adolescent and Young Adult (AYA) Cancer Survivorship Practices: An Overview , 2021, Cancers.
[3] K. Derwich,et al. Acute Lymphoblastic Leukemia in Adolescents and Young Adults: A Polish Perspective. , 2021, Journal of adolescent and young adult oncology.
[4] L. Soanes,et al. Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE) , 2021, ESMO open.
[5] A. Jemal,et al. Cancer statistics for adolescents and young adults, 2020 , 2020, CA: a cancer journal for clinicians.
[6] P. Nathan,et al. The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study , 2019, Cancer medicine.
[7] J. Richman,et al. Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment , 2018, Cancer Epidemiology, Biomarkers & Prevention.
[8] K. Dunleavy,et al. Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective. , 2018, Blood.
[9] A. Baruchel,et al. Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children? , 2018, Blood.
[10] J. Malvar,et al. A prospective, observational cohort study comparing cancer clinical trial availability and enrollment between early adolescents/young adults and children , 2018, Cancer.
[11] J. Sandlund,et al. Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum. , 2016, Hematology. American Society of Hematology. Education Program.
[12] D. Deapen,et al. Case‐linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute‐Designated comprehensive cancer center , 2015, Cancer.
[13] M. Stevens,et al. Trends in survival for teenagers and young adults with cancer in the UK 1992–2006 , 2015, European journal of cancer.
[14] Ahmedin Jemal,et al. Childhood and adolescent cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[15] L. Harlan,et al. Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] C. Bloomfield,et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. , 2008, Blood.
[17] A. Bleyer,et al. Cancer in 15- to 29-year-olds by primary site. , 2006, The oncologist.
[18] P. Sonneveld,et al. [Adolescents with acute lymphatic leukaemia achieve significantly better results when treated following Dutch paediatric oncology protocols than with adult protocols]. , 2005, Nederlands tijdschrift voor geneeskunde.
[19] S. Leeder,et al. A population based study , 1993, The Medical journal of Australia.
[20] S. Gomez,et al. Adoption of pediatric‐inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population‐based study , 2017, Cancer.
[21] P. Mahadevan,et al. An overview , 2007, Journal of Biosciences.
[22] J. Sandlund. Should adolescents with NHL be treated as old children or young adults? , 2007, Hematology. American Society of Hematology. Education Program.